Results 261 to 270 of about 9,263,948 (394)

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Primary Gastrointestinal EBV-Associated Classical Hodgkin Lymphoma in Crohn Disease on Anti-TNF-α Therapy: A Rare Association. [PDF]

JGH Open
Collins K, Toklu A, Dave N, Mesa H.
europepmc   +1 more source

Hodgkin's disease. I. [PDF]

BMJ, 1967
openaire   +6 more sources

Endocrine Implications of Thyroid Incidentalomas Detected During Lymphoma Staging With 18F‐Fluorodeoxyglucose Positron Emission Tomography

Clinical Endocrinology, EarlyView.
ABSTRACT Objective This study investigated the prevalence, characteristics, and endocrine implications of thyroid incidentalomas detected during lymphoma staging using FDG‐PET/CT. Design Retrospective cohort study. Patients A total of 795 adult patients with lymphoma who underwent FDG‐PET/CT for staging at a tertiary oncology centre were included ...
Marcos Tadashi Kakitani Toyoshima, Roberta Morgado Ferreira Zuppani, Isabelle Pinheiro Amaro, Camila Regina Pereira Batista de Macedo, Ricardo Miguel Costa de Freitas, Rodrigo Dolphini Velasques, Juliana Pereira, Rafael Loch Batista, Debora Lúcia Seguro Danilovic, Delmar Muniz Lourenço Jr., Ana O. Hoff   +10 more
wiley   +1 more source

Emerging trends and disparities in mortality due to coexisting non-Hodgkin's lymphoma and respiratory infections: A U.S. nationwide retrospective analysis from 1999 to 2020. [PDF]

Medicine (Baltimore)
Saeed H, Ali M, Ahmad MH, Babar I, Javeria S, Zabeehullah, Rasheed CF, Arshad Shahani H, Sehbai A.   +8 more
europepmc   +1 more source

Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis

Cancer, 1993
P. Mauch, L. Kalish, M. Kadin, C. Coleman, R. Osteen, S. Hellman   +5 more
semanticscholar   +1 more source

Frontline brentuximab vedotin-based therapy for newly diagnosed classical Hodgkin lymphoma: a meta-analysis of randomized controlled trials. [PDF]

Front Oncol
Yang Y, Liu SR, Wang L, Zhang R, Xie J.
europepmc   +1 more source

Indications of liver biopsy in the evaluation of Hodgkin 's disease

, 2000
A Rémond
openalex   +1 more source

The role of interleukin-3 and stem cell factor in classical Hodgkin disease

, 2002
Donatella Aldinucci, Valter Gattei
openalex   +1 more source

Patients With Relapsed Large B‐Cell Lymphoma After 12 Months Have a Similarly Poor Prognosis to Those Relapsing Within 12 Months

European Journal of Haematology, EarlyView.
ABSTRACT Chimeric antigen receptor T‐cell therapy (CART) has replaced salvage immunochemotherapy followed by high‐dose chemotherapy and autologous stem cell transplantation (HDT‐ASCT) as the preferred second‐line treatment for early relapsed (< 12 months) large B‐cell lymphoma (LBCL).
Hilde T. van der Galiën, Hilde A. M. Kooistra, Robby Kibbelaar, Nic J. G. M. Veeger, Marcel Nijland, Gerwin Huls, Tom van Meerten, Rozemarijn S. van Rijn, on behalf of The Hemobase Population Registry Consortium, Gerrit Jan Veldhuis, Gerhard Woolthuis, Leonie van der Burg, Bas van Rees, Mels Hoogendoorn, Bas Franken, Esther de Waal, Rozemarijn van Rijn, Peter Joosten, Hilde van der Galiën, Eric van Roon, Sjoerd Hovenga, Frank Schipper, Harmen van Kamp, Adrian Kruit, Huib Storm, Harry de Wit, Willeke Ferket‐Franken, Wilma Smit, Renske Vlasman, Robby Kibbelaar, Roy Jurhill, Sophie Dijkhuizen, Elise van der Logt, Melvin Kilsdonk   +33 more
wiley   +1 more source